Related references
Note: Only part of the references are listed.Genomic correlates of clinical outcome in advanced prostate cancer
Wassim Abida et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Biochemical and structural investigations clarify the substrate selectivity of the 2-oxoglutarate oxygenase JMJD6
Md Saiful Islam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Editorial: The Development of New Classes of Hypoxia Mimetic Agents for Clinical Use
Ruoli Chen et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Promotion of adipogenesis by JMJD6 requires the AT hook-like domain and is independent of its catalytic function
Pablo Reyes-Gutierrez et al.
PLOS ONE (2019)
Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer
Adam Sharp et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Jumonji domain-containing 6 (JMJD6) identified as a potential therapeutic target in ovarian cancer
Heng Zheng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
Targeting Bromodomain and Extra-Terminal (BET) Family Proteins in Castration-Resistant Prostate Cancer (CRPC)
Jonathan Welti et al.
CLINICAL CANCER RESEARCH (2018)
Inhibitors of both the N-methyl lysyl- and arginyl-demethylase activities of the JmjC oxygenases
Joanna Bonnici et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2018)
Histone demethylase JMJD1A promotes alternative splicing of AR variant 7 (AR-V7) in prostate cancer cells
Lingling Fan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Alternative splicing in prostate cancer
Alec Paschalis et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Bromodomain Drug Discovery - the Past, the Present, and the Future
Mehrosh Pervaiz et al.
CHEMICAL RECORD (2018)
JMJD6 and U2AF65 co-regulate alternative splicing in both JMJD6 enzymatic activity dependent and independent manner
Jia Yi et al.
NUCLEIC ACIDS RESEARCH (2017)
Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration- Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide
Emmanuel S. Antonarakis et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
Karim Fizazi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials
Tzu-Lan Yeh et al.
CHEMICAL SCIENCE (2017)
Jmjd6, a JmjC Dioxygenase with Many Interaction Partners and Pleiotropic Functions
Janice Kwok et al.
FRONTIERS IN GENETICS (2017)
canSAR: an updated cancer research and drug discovery knowledgebase
Joseph E. Tym et al.
NUCLEIC ACIDS RESEARCH (2016)
BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate Cancer
Irfan A. Asangani et al.
MOLECULAR CANCER RESEARCH (2016)
Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting
E. S. Antonarakis et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2016)
Arginine demethylation is catalysed by a subset of JmjC histone lysine demethylases
Louise J. Walport et al.
NATURE COMMUNICATIONS (2016)
The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis
Olga Aprelikova et al.
CLINICAL EPIGENETICS (2016)
The oxygenase Jmjd6-a case study in conflicting assignments
Angelika Boettger et al.
BIOCHEMICAL JOURNAL (2015)
Integrative Clinical Genomics of Advanced Prostate Cancer
Dan Robinson et al.
CELL (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
Rapid Induction of Androgen Receptor Splice Variants by Androgen Deprivation in Prostate Cancer
Ziyang Yu et al.
CLINICAL CANCER RESEARCH (2014)
canSAR: updated cancer research and drug discovery knowledgebase
Krishna C. Bulusu et al.
NUCLEIC ACIDS RESEARCH (2014)
Jumonji domain containing protein 6 (Jmjd6) modulates splicing and specifically interacts with arginine-serine-rich (RS) domains of SR- and SR-like proteins
Astrid Heim et al.
NUCLEIC ACIDS RESEARCH (2014)
Mechanisms of the androgen receptor splicing in prostate cancer cells
L. L. Liu et al.
ONCOGENE (2014)
JMJD6 Promotes Colon Carcinogenesis through Negative Regulation of p53 by Hydroxylation
Feng Wang et al.
PLOS BIOLOGY (2014)
High expression of JMJD6 predicts unfavorable survival in lung adenocarcinoma
Ji Zhang et al.
TUMOR BIOLOGY (2013)
Studies of H3K4me3 demethylation by KDM5B/Jarid1B/PLU1 reveals strong substrate recognition in vitro and identifies 2,4-pyridine-dicarboxylic acid as an in vitro and in cell inhibitor
Line H. Kristensen et al.
FEBS JOURNAL (2012)
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
MATS: a Bayesian framework for flexible detection of differential alternative splicing from RNA-Seq data
Shihao Shen et al.
NUCLEIC ACIDS RESEARCH (2012)
JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer
Yi Fang Lee et al.
BREAST CANCER RESEARCH (2012)
Molecular signatures database (MSigDB) 3.0
Arthur Liberzon et al.
BIOINFORMATICS (2011)
Inhibition of 2-oxoglutarate dependent oxygenases
Nathan R. Rose et al.
CHEMICAL SOCIETY REVIEWS (2011)
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Johann S. De Bono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
TopHat-Fusion: an algorithm for discovery of novel fusion transcripts
Daehwan Kim et al.
GENOME BIOLOGY (2011)
Crystal Structure of the 2-Oxoglutarate- and Fe(II)-Dependent Lysyl Hydroxylase JMJD6
Monica Mantri et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
AmiGO: online access to ontology and annotation data
Seth Carbon et al.
BIOINFORMATICS (2009)
Jmjd6 Catalyses Lysyl-Hydroxylation of U2AF65, a Protein Associated with RNA Splicing
Celia J. Webby et al.
SCIENCE (2009)
Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance
Scott M. Dehm et al.
CANCER RESEARCH (2008)
JHDM2A, a JmjC-containing H3K9 dernethylase, facilitates transcription activation by androgen receptor
Kenichi Yamane et al.
CELL (2006)
Biology of progressive, castration-resistant prostate cancer: Directed therapies targeting the androgen-receptor signaling axis
HI Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Molecular characterization of human prostate carcinoma cell lines
A van Bokhoven et al.
PROSTATE (2003)
FIH-1:: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity
PC Mahon et al.
GENES & DEVELOPMENT (2001)
The Protein Data Bank
HM Berman et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
